Companies
Organ-on-chip & MPSreported

MEPSGEN

Seoul-based developer of MEPS-X human microphysiological systems for toxicity and efficacy testing; also sells lipid nanoparticle manufacturing systems.

Related deals

Related updates

No related news yet.